Physicians' Academy for Cardiovascular Education
Podcast: Integrating EPA based therapy in the management of residual CV risk

Podcast: Integrating EPA based therapy in the management of residual CV risk

Podcast - Oct. 8, 2021 - Prof. Ph. Gabriel Steg, MD

What is the role of icosapent ethyl in lowering residual CV risk? Listen to the podcast by prof. Steg, who answers this question by presenting observations from trials with EPA-based therapies.

Listen to the podcast: